Status:
COMPLETED
NuGa (Nutrition for Gastric Cancer Patients)
Lead Sponsor:
Seoul National University Hospital
Conditions:
Gastric Cancer
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
The objective of this pilot study is to evaluate the feasibility and efficacy of Rhexium Onco Nutrition, HDT-202 for post-operative care in patients who have undergone gastrectomy.
Detailed Description
1. A total of 4 visits will be performed. 2. At the screening visit,subject's written informed consent, assessing the inclusion/exclusion criteria and assigning enrollment numbers to eligible subjects...
Eligibility Criteria
Inclusion
- Patient who voluntarily signs the informed consent form for this study
- Age of ≥19 years old
- Patient who has undergone therapeutic gastrectomy after a diagnosis of gastric cancer
- Able to eat food orally after gastrectomy
- Patient who possesses an Android OS based mobile device and is capable of using the investigational device.
Exclusion
- Other cancer or metastasis documented within 5 years prior to screening
- Ongoing or planned enteral tube feeding or total parenteral nutrition
- Other clinically significant medical or psychiatric findings based on which the individual is considered by the investigator to be ineligible
- Individual who possesses a mobile device on which the application is unable to be installed and/or run normally for technical reasons
- Individual who, in the opinion of the investigator, has difficulty understanding how to use the investigational device or is unlikely to comply with other study procedures
Key Trial Info
Start Date :
March 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 8 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04800991
Start Date
March 17 2021
End Date
October 8 2021
Last Update
October 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Surgery, Seoul National University Hospital
Seoul, South Korea, 110-744